CRISPR/Cas12aAuNPs

Zishi Deng1, Xuhua Mao2, Yeling Yang3

  • 1School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau SAR, 999078, China; Materials Artificial Intelligence Center, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.

Biosensors & bioelectronics
|September 6, 2025
PubMed
概括

一个新的护理点平台使用CRISPR/Cas12a和表面等离子效应进行快速,无放大的人类乳头瘤病毒 (hrHPV) 高风险的基因定型. 这种具有成本效益的方法在预防宫癌方面具有很高的灵敏度.